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RESEARCH ARTICLE
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ABSTRACT
Context: Polyphenols and flavonoids in artichoke leaf tincture (ALT) protect cells against oxidative
damage.
Objectives: We examined ALT effects on deoxyribonucleic acid (DNA) damage and lipid profiles in rat
plasma and gene expression in rat aorta [haemeoxygenase-1 (HO1), haemeoxygenase-2 (HO2), NADPH oxi-
dase 4 (NOX-4), monocyte chemoattractant protein-1 (MCP-1) and nuclear factor (erythroid-derived 2)-like
2 (Nrf2)].
Materials and methods: Eighteen male Wistar albino rats were divided into three groups (n¼ 6/group):
The control group (CG) was fed with standard pellet chow for 11 weeks; the AD group was fed for a simi-
lar period of time with pellet chow supplemented with 2% cholesterol, 3% sunflower oil and 1% sodium
cholate. The ADA group was fed with pellet chow (for 1 week), the atherogenic diet (see above) for the
following 4 weeks and then with ALT (0.1mL/kg body weight) and atherogenic diet for 6 weeks.
According to HPLC analysis, the isolated main compounds in ALT were chlorogenic acid, caffeic acid,
isoquercitrin and rutin.
Results: Normalized HO-1 [0.11 (0.04–0.24)] and MCP-1 [0.29 (0.21–0.47)] mRNA levels and DNA scores
[12.50 (4.50–36.50)] were significantly lower in the ADA group than in the AD group [0.84 (0.35–2.51)],
p¼ 0.021 for HO-1 [0.85 (0.61–3.45)], p¼ 0.047 for MCP-1 and [176.5 (66.50–221.25)], p¼ 0.020 for DNA
scores. HO-1 mRNA was lower in the ADA group than in the CG group [0.30 (0.21–0.71), p¼ 0.049].
Conclusions: Supplementation with ALT limited the effects of the atherogenic diet through reduced
MCP-1 expression, thereby preventing oxidative damage.
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Current data inform us that the most common causes of death
worldwide are atherosclerosis-associated diseases (Hansson 2005;
Go et al. 2014), evidence suggests that common risk factors for
atherosclerosis, such as hypercholesterolemia (Jandaghi et al.
2016; Yousefi et al. 2017), hypertension (Ardalani et al. 2016),
obesity (Furukawa et al. 2017; Niemann et al. 2017), a sedentary
way of life (Gomez-Cabrera et al. 2008) and smoking (Niemann
et al. 2017), all increase the production of free reactive oxygen
species (ROS) which leads to oxidative modification of deoxy-
ribonucleic acid (DNA), proteins and lipids, causing changes in
their regular functions (De Bont and Van Larebeke 2004) which
can contribute to further escalation of atherosclerotic processes
(Harman 1956). Attenuation of atherosclerosis development
requires changes in life-style habits, use of certain drugs and
often certain non-pharmacologic supplementation. Artichoke
(Cynara scolymus L. [Asteraceae]), a thistle-like plant in the aster
family, is well known for its antioxidant and plasma lipid-lowering
properties (Rondanelli et al. 2013; Sahebkar et al. 2017).
For many years, polyphenols in artichoke leaf were thought to
protect against oxidative damage through free radical scavenging
(D’Antuono et al. 2015). Polyphenols mainly interact with recep-
tors or enzymes involved in signal transduction events resulting
in induction of antioxidant and/or anti-inflammatory effects
(Pandey and Ibrahim 2009). Several phytochemicals present in
the artichoke leaf regulate the expression of genes involved in
cellular defence by the activation of nuclear factor (erythroid-
derived 2)-like 2 (Nrf2) (Jeong et al. 2006). Activation of Nrf2
leads to the production of cytoprotective proteins including nico-
tinamide adenine dinucleotide phosphate (NADPH) dehydrogen-
ase, glutathione S-transferase, quinone 1, glutathione peroxidase,
glutamate-cysteine ligase, peroxiredoxin I and haemeoxygenase-1
(HO-1) which play crucial roles in cellular defence by facilitating
removal of ROS (Mulcahy et al. 1997; Katsuoka et al. 2005; Tosi
et al. 2011). In addition, Nrf2 inhibits the expression of pro-
inflammatory mediators including cytokines, chemokines and
adhesion molecules (Kim et al. 2010). A reduction in ROS and
inflammatory mediators prevents oxidative modification of blood
lipoproteins and diminishes the risk of arteriosclerosis and cor-
onary heart disease. Furthermore, phenolic acids, including
chlorogenic acid, have been shown to affect DNA methylation
(Lee and Zhu 2006). Artichoke leaf extract has also been shown
to lower total plasma cholesterol, by inhibiting cholesterol
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biosynthesis in primary cultured rat hepatocytes (Gebhardt
1998). The majority of data regarding the role of polyphenols
and flavonoids in artichoke leaf on gene expression in athero-
sclerosis are from in vitro studies. In contrast, the number of
studies in animal models is limited.
To further understand the effect of a lipid-rich diet and a
lipid-rich diet containing artichoke leaf tincture (ALT) on path-
ways that contribute to atherosclerotic processes, we investigated
the expression of several genes [transcription factor Nrf2, cyto-
protective enzymes (HO-1, HO-2), NADPH oxidase 4 (NOX-4)
and monocyte chemoattractant protein-1 (MCP-1)] in rat aorta.
In addition, we examined stress-induced oxidative DNA damage
and key lipid component changes in rat plasma by measuring
high-density lipoprotein cholesterol (HDL-cholesterol) and trigly-
ceride (TG) concentrations and calculating the atherogenic index,
log (TG/HDL-cholesterol) ratio, a known marker for the pres-
ence of small dense low-density lipoprotein particles (sdLDL).
Materials and methods
For experimental purposes, we used commercial ALT produced
by the Institute for Medicinal Plant Research “Dr. Josif Pancic”,
Belgrade, Serbia. ALT was prepared from dried primary rosettes
from artichoke plants. Single percolation extraction during 24 h
was performed using a mixture of ethanol and water (38:62,
w/w). The extract was left for 3 d and then filtered. The ALT
contained 20% of the plant material by weight. According to the
manufacturer for medicinal purposes, the recommended dose of
ALT is 30 drops of tincture three times per day or 90 drops
daily. For a grown up adult with an average body weight of
70 kg, the dose of ALT is 1.29 ALT drops per kg body weight.
Artichoke tincture which we used contained 20 drops/mL, so the
exact calculation in mL for 1.29 drops was 64.5mL/kg per body
weight. For ease of measurement and possible loss during treat-
ment, the dose of ALT for rats was round to 100 mL/kg per body
weight. The dose was calculated using the rats’ average body
weight. Doses of ALT were recalculated once a week, according
to body weights of the rats.
Eighteen male Wistar albino rats (2 months old, weighing
150–190 g at the beginning of the experiment) were obtained
from the Military Medical Academy Farm (Belgrade, Serbia).
They were housed in groups of three in a controlled environment
with 12 h light/dark cycles and were allowed free access to
food and water. They were randomly divided into three groups
(n¼ 6/group). Group 1, the control group of rats which received
standard pellet chow (CG) for 11 weeks; group 2, rats fed with
normal pellet chow for 1 week and changed to an atherogenic
diet (standard pellet chow supplemented with 2% cholesterol, 3%
sunflower oil and 1% sodium cholate) for the next 10 weeks
(AD); group 3, rats fed with a normal diet for 1 week, the
atherogenic diet for the next 4 weeks and then fed with ALT
(0.1mL/kg body weight for 6 weeks (ADA) in the continued
presence of the atherogenic diet. ALT extract analysis showed
that the content of both cynarin and chlorogenic acid was 0.2%.
All experimental procedures and protocols conformed to insti-
tutional guidelines for the care and use of animals in research
(Ethics Committee of the Faculty of Pharmacy, University of
Belgrade and license number 5/10).
At the end of the feeding period, rats from each group were
fasted overnight and sacrificed the following morning. Blood was
immediately collected from the heart into heparinized tubes.
Whole blood was centrifuged for 10min at 3000 rpm; plasma was
separated, frozen and stored at 80 C until analysis. Portions of
aorta were excised and immediately frozen in liquid nitrogen and
kept at 80 C until RNA isolation was performed.
In plasma, both TG and HDL-cholesterol were assayed by
routine enzymatic methods using an ILab 300þ analyser
(Instrumentation Laboratory, Milan, Italy) and Randox
Laboratories (Armdore, UK) reagents.
The quality of isolated aorta RNA was determined by measur-
ing absorbance ratios at 260 and 280 nm (A260/280) as well as
260 and 230 nm (A260/230) to estimate protein and organic
impurities, respectively. Samples with an A260/280 ratio greater
than 1.8 and an A260/230 ratio greater than 2.4 were used. RNA
integrity was evaluated by electrophoresis. Samples with both
subunits clearly visible were used. All extracted RNAs were then
stored at 80 C prior to reverse transcription (RT) reactions.
RT and real-time PCR were carried out on the 7500 Real-
Time PCR System (Applied Biosystems, Foster City, CA) using
TaqManVR reagent-based chemistry. RT was performed with
MultiScribeTM Reverse Transcriptase, random primers and RNase
inhibitor using a high-capacity cDNA reverse transcription kit
(Applied Biosystems, Foster City, CA) following the instructions
from the manufacturer.
Quantitative real-time PCR was performed using TaqManVR
50-nuclease gene expression assays (Applied Biosystems, Foster
City, CA) for HO1, HO2, NOX-4, MCP-1 and Nrf2 genes. Nine
reference genes were examined (GADPH, ACTB, TBP, SFN,
B2M, HPRT1, UCB, HMBS and PPIA). The geNorm VBA applet
for Microsoft Excel was used to determine the most stable gene
from the set of tested genes. HMBS was proved to be the most
stable housekeeping gene for all three tissues. The results were
analyzed in real-time mode using SDS Version 1.4.0.25 software
(SPSS, Chicago, IL). Data were expressed as a ratio between the
target gene mRNA level and the mRNA level of the housekeep-
ing gene.
Part of the fresh whole blood was used for the determination
of single- and double-strand breaks in DNA using the single-cell
gel electrophoresis (comet assay). The alkaline comet assay was
performed as originally described by Singh et al. (1988) with
slight modifications (Sopic et al. 2014). Whole blood was mixed
with 0.67% w/v low melting point agarose (Serva, Reno, NV)
and placed onto a slide (76 26mm) previously coated with 1%
w/v normal melting agarose (Serva, Reno, NV) and covered with
a coverslip (24 50mm). After cooling to 4 C, the coverslip was
removed and a layer of 0.5% w/v low melting point agarose was
added and left at 4 C for 5min. Slides were then dipped into
precooled lysis solution [2.5M NaCl (Serva, Reno, NV), 100mM
Na2EDTA (Merck), 10mM Tris (Merck, Kenilworth, NJ), 1%
Triton X-100 (Serva, Reno, NV), pH adjusted to 10 with NaOH
(Serva, Reno, NV)] and left overnight in the lysis solution at 4 C
for removal of cellular proteins. After lysis, slides were placed in
a submarine electrophoresis tank with fresh alkaline electrophor-
esis buffer (1mM Na2EDTA, 3mM NaOH, pH 13.5) for 30min
at 4 C which allows the DNA to unwind and express alkali-labile
damage. Electrophoresis was conducted at 4 C for 30min, 25V
and 300mA, using an Amersham-Pharmacia biotech electrophor-
esis power supply – EPC 601. Slides were washed with a neutral-
izing solution [0.4M Tris, pH 7.5, adjusted with HCl (Serva,
Reno, NV)] and then placed in methanol for 30min for slide
preservation. Preserved slides were kept at 4 C (Woods et al.
1999). Before examination the slides were regenerated in cold
water for 30min, dried out, and stained with ethidium bromide
(Serva, Reno, NV). Slides were examined using an Olympus BX
50 microscope (Olympus, Tokyo, Japan). For every sample,
two slides were prepared. On every slide 50 comets were scored
PHARMACEUTICAL BIOLOGY 139
(100 comets per sample). The cells were classified [according to
the method suggested by Collins et al. (1997)] into five classes
0–4 (from undamaged¼ 0, to maximum damaged¼ 4). The vis-
ual score of each class was calculated by multiplication of the
percentage of cells in the appropriate comet class by value of the
class. The total visual comet score (DNA score) was the sum of
the scores in the five comet classes. Thus, DNA score range from
0 (all undamaged cells) to 400 (all maximally damaged cells).
Every slide was scored independently by two people. The average
score for every sample was calculated to minimize subjectivity of
obtained results. Prior to this study, we performed a dummy run
to examine variance within our method. The intra-assay and
inter assay coefficients of variance were 4.6% and 8.5%,
respectively.
The content of cynarin and chlorogenic acid in ALT was
determined by a high-performance liquid chromatography
(HPLC). The HPLC system consisted of an Agilent Technologies
HP 1200 (binary pump) and a DAD detector (Agilent, Santa
Clara, CA). For chromatographic separation a ZORBAX Eclipse
Plus C18 Analytical (4.6 250mm, 5 lm) (Agilent, Santa Clara,
CA) column was used. A gradient was generated using two solu-
tions: A [phosphoric acid R: water R (0.5: 99.5, v/v)] and B
[phosphoric acid R: acetonitrile R (0.5: 99.5, v/v)] (1st min
92% mobile phase A and 8% mobile phase B; 1–20th min lin-
ear change from 92% to 75% mobile phase A and from 8% to
25% mobile phase B; 20–33rd min 75% mobile phase A and 25%
mobile phase B; 33–35th min linear change from 75% to 0%
mobile phase A and from 25% to 100% mobile phase B). The
flow rate was 1.2mL/min. The column temperature was set at
40 C and the detection wavelength was 330 nm. Reference solu-
tions of cynarin and chlorogenic acid were prepared in methanol
(Serva, Reno, NV) and the concentration of both compounds
was 0.025mg/mL. ALT for HPLC analysis was prepared by dilut-
ing 1mL of ALT to 10mL with a mixture of water and methanol
(50:50, v/v). The prepared solution (1mL) was further diluted to
5mL with the same diluent.
Statistical methods
Comparisons of variables were performed using the Kruskal–Wallis
test with Mann–Whitney U test for subgroup differences.
The characteristics of the study populations are presented as
median values and interquartile range. Due to the dataset being
small, necessary assumption for the asymptotic method was not
met. Therefore, we used Monte Carlo simulation. The exact sig-
nificance level in the Monte Carlo method was calculated by
repeatedly sampling from a reference dataset (Roff and Bentzen
1989). Spearman correlation analysis was conducted to determine
relationships between examined parameters. Statistical analyses
were performed using PASWV
R
Statistic version 22 (SPSS Inc.,
Chicago, IL) and MicrosoftV
R
Office Excel 2007. A value of
p< 0.05 was considered statistically significant.
Results
Gene expression of HO1, HO2, NOX-4, MCP-1 and Nrf2 were
measured in rat aortas. Levels of both HO1 and MCP-1 mRNA
were significantly different between groups (p¼ 0.014 and
p¼ 0.049, respectively). The normalized level of HO-1 mRNA in
the ADA group [0.11 (0.04–0.24)] was significantly lower than
the level in both the CG [0.30 (0.21–0.71), p¼ 0.049] and AD
[0.84 (0.35–2.51), p¼ 0.021] groups (Figure 1). The normalized
MCP-1 mRNA level was higher in the AD group [0.85
(0.61–3.45)] than in the ADA group [0.29 (0.21–0.47), p¼ 0.047]
(Figure 2). There were no significant differences in the mRNA
levels of HO2, NOX-4 and Nrf2 between the three groups
(Figure 3).
In order to assess DNA damage caused by reactive oxygen
species generated upon the atherogenic diet DNA scores were
measured. DNA scores were different according to the type of
diet (p¼ 0.036). Rats fed an atherogenic diet had increased DNA
scores [176.5 (66.50–221.25)] compared with the atherogenic
diet supplemented with ALT [12.50 (4.50–36.50), p¼ 0.020]
(Figure 3). There was no difference in DNA score between the
CD and AD groups (Figure 4).
Plasma lipid parameters are shown in Table 1. HDL-
cholesterol levels across the CG, AD and ADA groups were
comparable, while the TG level was significantly lower in the
ADA group compared to the CG group (p¼ 0.023). In addition,
the atherogenic log (TG/HDL-cholesterol) ratio was significantly
lower in the ADA group compared to the CG group (p¼ 0.014).
Figure 1. Normalized HO-1 mRNA levels in aortas from rats fed different diets (after 10,000 repeated samples in Monte Carlo simulation). Significantly lower expres-
sion of HO-1 than in CG (p¼ 0.049). #Significantly lower expression of HO-1 than in AD (p¼ 0.021).
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Associations between lipid parameters, DNA scores and gene
expression of HO1, HO2, NOX-4, MCP-1 and Nrf2 were tested
using Spearman correlation analysis. In the CG group, DNA
scores highly negatively correlated with Nrf2 (r¼0.812,
p¼ 0.049) gene expression. In the AD group HDL-cholesterol
positively correlated with NOX-4 (r¼ 0.940, p¼ 0.048) and Nrf2
(r¼ 0.894, p¼ 0.041) gene expression. However, HDL-cholesterol
negatively correlated with HO-1 (r¼0.949, p¼ 0.048) gene
expression.
HPLC analysis of the ALT revealed the concentrations of
some of the compounds present in the ALT. Phenolic acids:
chlorogenic acid (778.7 lg/g) and caffeic acid (43.8 lg/g) and fla-
vonoids: isoquercitrin (1388.2 lg/g) and rutin (309.9 lg/g). Gallic
acid, hyperoside, quercetin, sakuranetin and rosmarinic acid were
not detected in the extract.
Discussion
Recent studies have expanded our knowledge regarding the
complex molecular mechanisms involved in atherogenesis.
Dyslipidemia is one of the well-established atherosclerotic risk
Figure 2. Normalized MCP-1 mRNA levels in aortas from rats fed different diets (after 10,000 repeated samples in Monte Carlo simulation). Significantly lower expres-
sion of MCP-1 than in AD (p¼ 0.047).
Figure 3. Normalized HO-2 mRNA (panel A), NOX-4 mRNA (panel B) and NLF2L2 mRNA (panel C) levels in aortas from rats fed different diets (after 10,000 repeated
samples in Monte Carlo simulation).
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factors found in a Western high-fat diet (Leon and Bronas 2009).
There have been numerous attempts to implement lipid-lowering
and antioxidative supplementation in diets in order to suppress
atherosclerosis development (Varady and Jones 2005). However,
convincing effects of food-derived supplements and their mecha-
nisms of antioxidant or anti-inflammatory behaviour are far
from complete and accepted.
Our current study has demonstrated positive effects of ALT
on both the plasma lipid profile and oxidative stress status bene-
ficial for the arterial wall. ALT’s phenolic acids (clorogenic and
caffeic acid) and flavonoids (isoquercitrin and rutin) are known
to have antioxidant properties. The DNA single and double
strand break score was lowest in the ADA group, indicating that
ALT-derived antioxidants managed to attenuate the harmful
effects of the atherogenic diet. In agreement with our findings, a
moderate but significant upregulation of DNA repair capacity in
lymphocytes was found after dietary supplementation with plants
rich in phenolic acids and flavonoids (Guarrera et al. 2007).
Despite the abundance of biological data demonstrating the anti-
oxidant activities of chlorogenic acids, controversy persists
around the notion that these compounds may be a potent antiox-
idants or pro-oxidants – depending on their concentration
(Morishita and Ohnishi 2001). Zan et al. (2013) demonstrated
that high concentrations of leaf and flower extracts of
C. scolymus L. induced DNA damage in blood cells. These results
indicate that artichoke tea should be consumed moderately.
Similarly, flavonoids have been reported to exert pro-oxidant
activity by elevation of free radicals (Cao et al. 1997).
On the other hand, there is evidence that the antioxidant
function of ALT may be mediated via the antioxidant responsive
element (ARE/EpRE) by activation of the transcription factor
Nrf2 (Jeong et al. 2006). Increased ROS can affect gene expres-
sion via translocation of Nrf2 to the nucleus where it can cause
upregulation of certain antioxidant genes for example HO-1
(Araujo et al. 2012). Although the AD group showed greater
DNA damage than the other groups, there was no increase in the
Nrf2 mRNA level. Only in the CG group was there negative cor-
relation of Nrf2 mRNA gene expression and DNA score.
Therefore, an atherogenic diet means increased oxidative stress/
DNA damage without change in Nrf2 mRNA gene expression,
but with increased HO-1 mRNA expression. Associations
between HO-1 gene expression and hydrogen peroxide have been
documented in other papers (Applegate et al. 1991). ALT supple-
mentation did not influence the level of Nrf2 mRNA. In our
recent paper (Crevar-Sakac et al. 2016), we showed that ALT
possesses antioxidative effects and that effects were probably suf-
ficient enough to decrease HO-1 and MCP-1 mRNA expression.
HO-1 expression is regulated at the transcriptional level and the
regulation of HO-1 mRNA in response to oxidative stress may
be induced by both transcriptional and post-transcriptional mod-
ulations that act independently (Gozzelino et al. 2010; Keene
2010).
MCP-1 is a key monocyte chemokine in atherosclerosis
(Gu et al. 1998). Using MCP-1- or MCP-1 receptor-deficient
mice to examine atherosclerosis, it was demonstrated that, in the
absence of MCP-1 or its receptor, there was a substantial reduc-
tion in arterial lipid deposition (Boring et al. 1998). MCP-1 is
induced in response to the activation of inflammatory NF-jB
pathways in macrophages. As flavonoids possess various anti-
inflammatory properties, they are potent inhibitors of NF-jB sig-
nalling (Rahman et al. 2006), but are also potent activators of
Nrf2 mRNA. Our data are consistent with the idea that ALT
Figure 4. DNA scores in aortas from rats fed different diets (after 10,000 repeated samples in Monte Carlo simulation). Significantly lower DNA score than in AD
(p¼ 0.020).
Table 1. Lipid status of Wistar rats on different diet regimes.
Parameter CG AD ADA p
HDL-cholesterol, mmol/L 0.49 (0.41–0.53) 0.42 (0.36–0.58) 0.45 (0.34–0.55) 0.724
TG, mmol/L 0.79 (0.57–0.89) 0.52 (0.44–0.65) 0.39 (0.32–0.56)a, 0.042
log(TG/HDL-cholesterol) 0.21 (0.034–0.290) 0.076 (0.017 to 0.180) 0.014 (0.088 to 0.112)a, 0.018
All results are presented as median and interquartile range.
aSignificantly lower than CG.p< 0.05. Kruskall–Wallis test than Mann–Whitney U test. After 10,000 repeated samples in Monte Carlo simulation.
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suppresses inflammation and ROS production and particularly
MCP-1 expression. It was also found that HO-1 attenuated
MCP-1 mRNA expression in U937 human monocytic cells
(Shokawa et al. 2006). MCP-1 mRNA, which can be induced by
oxidative stress (Reape and Groot 1999), was not altered by the
atherogenic diet. Therefore, we can presume that upregulation of
HO-1 attenuated MCP-1 mRNA expression (Shokawa et al.
2006) and in doing so weakened HO-1’s capability to compensate
stress induced by the atherogenic diet. There was no increase in
gene expression of pro-atherogenic MCP-1 and there was no
increase in HO-1 mRNA expression, suggesting a protective role
of ALT.
According to previous studies, certain saturated fatty acids
stimulate adipocytes to generate ROS in a NOX-4-dependent
fashion linking NFjB activation and expression of monocyte
chemotactic factor genes (Yeop et al. 2010). In a study by
Umemoto et al. (2013), pre-exposure of cells to HDL inhibited
the translocation of NOX-4 to lipid deposits in the plasma mem-
brane and decreased ROS generation. None of the treatments
in our study induced any changes in NOX-4 mRNA or HDL-
cholesterol. However, in the AD group, NOX-4 gene expression
was positively associated with HDL-cholesterol. Further studies
will lead to a deeper understanding of its role in atherosclerosis.
A high logTG/HDL-cholesterol ratio (i.e., high atherogenic
index) shows tendency towards sdLDL particle formation which
is more atherogenic than large, buoyant particles (Dobiasova and
Frohlich 2001). In our current study, we found a significantly
lower logTG/HDL-cholesterol ratio in the ADA group compared
with the CG group. In addition, ALT caused a significant
decrease in TG. According to a study by Shimoda et al. (2003),
artichoke extract inhibits gastric emptying which could in part
explain its hypotriglyceridemic influence. A study by Qiang et al.
(2012) indicated that ALE could decrease both TG and choles-
terol in hamsters only after prolonged atherogenic feeding.
Several other studies which analyzed compound rich in flavo-
noids and antioxidants came to similar results. Namely, a study
from Jandaghi et al. (2016) demonstrated that Melissa officinalis
supplementation as a rich source of antioxidants and bioactive
compounds can be effective in remission of LDL and AST levels
in patients with borderline hyperlipidemia, while Yousefi et al.
(2017) showed that Fenugreek seeds supplementation, as a phen-
olic-rich herb, can be effective in the reduction of some lipid
profile in patients with borderline hyperlipidemia. Furthermore,
antihypertensive activity of Rhus coriaria fruits could be attrib-
uted to flavonoids, which are the main chemical constituents of
this plant, demonstrating the powerful cardiovascular protective
activity of these compounds (Ardalani et al. 2016).
The qualitative and quantitative variability of phenolic and fla-
vonoid content in ALT depends on plant genetic diversity, the
physiological stage of plant development (harvest time), climatic
conditions during plant growth, extract production (Ceccarelli
et al. 2010) and applied dose (Jacociunas et al. 2012). We used
the commercial ALT dosage to imitate conditions recommended
for human use in the case of dyslipidemia treatment. However,
additional studies are needed to explore and compare the influ-
ence of different ALT doses on molecular pathways that contrib-
ute to atherosclerotic processes.
Conclusions
ALT exerts its beneficial effect on the arterial vessel wall through
a reduction in oxidative stress and by establishing a more favour-
able plasma lipid profile. ALT’s effect on an atherogenic diet
appears to be mediated through diminished MCP-1 expression
(DNA damage reduction) and a lowered atherogenic TG/HDL-
cholesterol ratio. The atherogenic diet induced HO-1 mRNA
expression most likely in response to increased oxidative stress.
The antioxidative effects of ALT were clearly sufficient to inhibit
the atherogenic diet-induced increase in HO-1 mRNA. This
in vivo study confirms the results from previous in vitro studies.
It would be interesting to perform a similar study in humans
using their peripheral blood mononuclear cells as distinct vessel-
wall imprints.
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